Filing Details
- Accession Number:
- 0001209191-17-042269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-29 16:01:52
- Reporting Period:
- 2017-06-27
- Filing Date:
- 2017-06-29
- Accepted Time:
- 2017-06-29 16:01:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-06-27 | 13,712 | $107.65 | 360,656 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-27 | 11,288 | $108.52 | 349,368 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 17,186 | Indirect | Nick Leschly 2001 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- The range of prices for the transaction reported on this line was $107.10 to $108.05. The average weighted price was $107.6530. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $108.10 to $109.00. The average weighted price was $108.5246. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.